For patients with stage IA non-small cell lung cancer (NSCLC), lung resections, including lobectomy and segmentectomy, are ...

There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small ...

Findings were similar for lung cancer-specific survival, according to the authors. For early-stage NSCLC, lobar r ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...

Cullinan Therapeutics has announced that its lead asset has aced a midstage lung cancer trial—but the biotech is keeping the ...

Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like ... New, Rare Type of Small Cell Lung Cancer Identified Sep. 11, 2024 ...

Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like ... targeted treatment for non-small cell lung cancer fails to work for some ...

The approval is based on findings from a phase 3 study which demonstrated the drug’s superiority over chemotherapy.

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

Chavez, MD, discusses how comprehensive genomic profiling may impact the treatment and clinical management of patients with small cell lung cancer.

Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel condensate-modulating mechanism of ...

Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery ...